Emergent BioSolutions Inc. (EBS)
Acquisition of Adapt Pharma and its Flagship Product NARCAN Nasal Spray Conference Call
August 28, 2018 05:00 PM ET
Executives
Bob Burrows - Vice President, Investor Relations
Dan Abdun-Nabi - Chief Executive Officer
Bob Kramer - President, Chief Operating Officer
Rich Lindahl - Executive Vice President, Chief Financial Officer
Adam Havey - Executive Vice President, Business Operations
Doug White - Senior Vice President and Devices Business Unit Head
Chris Frech - Senior Vice President, Global Government Affairs
Analysts
Brandon Folkes - Cantor Fitzgerald
David Maris - Wells Fargo
Chris Staral -